Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

Quetiapine was approved in 2009 and 2010 for the adjunctive treatment of major depressive disorder (MDD) in several countries worldwide, including the European Union, Canada, the United States, and Australia. These approvals followed three industry sponsored trials of quetiapine versus placebo ad...